BOSTON (AP) — BOSTON (AP) — Elicio Therapeutics, Inc. (ELTX) on Thursday reported a loss of $7.7 million in its fourth quarter.
The Boston-based company said it had a loss of 49 cents per share.
For the year, the company reported a loss of $39.6 million, or $2.58 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ELTX at https://www.zacks.com/ap/ELTX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
